Positive Pregnancy Program

NCT03073421 | Completed

• 1 other identifier: 12-124
• Study Type: interventional
• Target: 25
• Locations: 0 countries
• Sites: N/A

Brief Summary

The Positive Pregnancy Program is an innovative, unique, interprofessional model of care for HIV-positive pregnant women. This program has been in place at St. Michael's Hospital for five years. This study is important because it will allow for a critical evaluation of the Program, and to identify strengths and weaknesses. This will in turn provide the opportunity to improve delivery of care for HIV positive women.

Conditions

HIV Positive Pregnant Women

Outcome Measures

Primary Outcomes (2)

• Degree of satisfaction with P3 program during antenatal period

  A qualitative 2 hour interview will be conducted with HIV positive pregnant women taking part in the P3 program. The first interview will be timed to occur late in the third trimester, at approximately 36 weeks gestation. This interview will allow an evaluation of women's experiences during antenatal care. The second interview will occur in the post partum period, and will be timed to coincide with the post partum visit at six weeks after birth. This interview will allow an evaluation of women's experiences in the hospital, during labour and delivery, and on the post partum floor.

  36 weeks gestation

• Post-partum degree of satisfaction with P3 program

  The second interview will occur in the post partum period, and will be timed to coincide with the post partum visit at six weeks after birth. This interview will allow an evaluation of women's experiences in the hospital, during labour and delivery, and on the post partum floor.

  6 weeks post-partum

Study Arms (1)

HIV positive pregnant women

OTHER

HIV positive pregnant women who took part in the P3 program will take part in a 2-hour qualitative interview.

Other: Qualitative interview

Interventions

Qualitative interview OTHER

This interview will be 2 hours in length and will be conducted with a Peer Research Assistant (PRA). The PRAs will be women living with HIV.

HIV positive pregnant women

Eligibility Criteria

• Gender Eligibility Details: Pregnant women
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• HIV positive pregnant women who took part in P3 program

You may not qualify if:

• HIV negative
• did not take part in P3 program

Sponsors & Collaborators

• Unity Health Toronto: lead

Study Officials

• Mark Yudin, MD

  Unity Health Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 22, 2017
• First Posted: March 8, 2017
• Study Start: June 29, 2012
• Primary Completion: September 1, 2016
• Study Completion: September 1, 2016
• Last Updated: March 8, 2017

Record last verified: 2017-03

Data Sharing

• IPD Sharing: Will not share